NSEClarification - Financial Results9 Sept 2026 · 9 Sept 2026, 12:56 pm

Clarification - Financial Results

Nath Bio-Genes (India) Limited · NATHBIOGEN

✦ AI SummaryResults

NSE-listed Nath Bio-Genes (India) Limited has received a clarification request from the exchange regarding its financial results for the quarter ended June 30, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

The Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.